clopidogrel and Arteriosclerosis

clopidogrel has been researched along with Arteriosclerosis in 73 studies

Research

Studies (73)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	22 (30.14)	18.2507
2000's	46 (63.01)	29.6817
2010's	4 (5.48)	24.3611
2020's	1 (1.37)	2.80

Authors

Authors	Studies
Abe, K; Ikeda, Y; Kitagawa, K; Kitazono, T; Matsumoto, M; Minematsu, K; Nagao, T; Nagata, I; Nanto, S; Nishikawa, M; Ogawa, A; Shirai, T; Tanahashi, N; Toyoda, K; Uchiyama, S; Yamagami, H	1
Giacomini, T; Prato, G; Rossi, A; Severino, M; Verrina, E	1
Eckl, S; Ensminger, SM; Goldmann, K; Heim, C; Koch, N; Preidl, R; Ramsperger-Gleixner, M; Spriewald, BM; Weyand, M	1
Erdmann, E; Müller-Ehmsen, J	1
Abele, S; Ensminger, SM; Hiemann, NE; Nieswandt, B; Ramsperger-Gleixner, M; Spriewald, BM; Weyand, M; Wollin, M	1
Abele-Ohl, S; Eckl, S; Ensminger, SM; Heim, C; Hoffmann, J; Ramsperger-Gleixner, M; Weyand, M	1
Batyraliev, TA; Besnili, F; Fettser, DV; Niiazova-Karben, ZA; Preobrazhenskiĭ, DV; Sidorenko, BA	1
Brinkman, WT; Chaikof, EL; Najibi, S; Terramani, TT	1
Dobrovol'skiĭ, AB; Komarov, AL; Kropacheva, ES; Mironova, IY; Naumov, VG; Panchenko, EP; Tarasova, TN; Titaeva, EV	1
Lecompte, T	1
Bae, HR; Cha, JK; Cheon, SM; Jeong, MH; Lee, KM; Lim, YJ; Park, KW	1
Hildebrandt, PR; Husted, SE; Kristensen, SD; Nielsen, HK; Rasmussen, LH; Ziegler, BK	1
Bhatt, DL; Hacke, W; Hirsch, AT; Ringleb, PA; Topol, EJ	1
Bogousslavsky, J; Brass, LM; Cimminiello, C; Csiba, L; Diener, HC; Kaste, M; Leys, D; Matias-Guiu, J; Rupprecht, HJ	1
Rao, U; Weston, C	1
Rodgers, JE; Steinhubl, SR	1
Geroulakos, G; Jagroop, IA; Matsagas, MI; Mikhailidis, DP	1
Ringleb, PA; Schellinger, PD; Schwark, C	1
Jacobson, AK	1
Lewis, SC; Warlow, CP	1
Bhatt, DL; Topol, EJ	1
Anand, SS; Tran, H	1
Butz, B; Feuerbach, S; Lenhart, M; Link, J; Paetzel, C; Pfister, K; Schleicher, T; Stern, U	1
Cavendish, JJ; Safani, M	1
Cheung, BM; Cheung, G; Kumana, CR; Lauder, IJ	1
Moussouttas, M	1
Herbert, JM; Savi, P	1
Kiss, RG	1
Bath, PM; Gray, L; Heptinstall, S; Leonardi-Bee, J; Weaver, CS; Zhao, L	1
Abele, S; Ensminger, SM; Fischlein, T; Harig, F; Hiemann, NE; Weyand, M; Wollin, M	1
Faxon, DP; Nesto, RW	1
Gaciong, Z	1
Jamieson, DG	1
Delépine, G; Durand, E; Malinovsky, JM; Murat, O; Nguyen, P	1
Boneu, B; Destelle, G	1
Keil, Tu	1
Hankey, GJ	1
Ferguson, JJ; Gonzalez, ER; Kannel, WB; Olin, JW; Raps, EC	1
Gonzalez, ER	1
Gonzalez, ER; Kannewurf, BS	1
Schrör, K	1
Dormandy, JA	1
Creager, MA	1
Priollet, P	1
Feret, B	1
Denninger, MH; Necciari, J; Serre-Lacroix, E; Sissmann, J	1
Chesebro, JH; Comerota, A; Hartmann, JR; Massin, EK; Raps, E; Wolf, PA; Zusman, RM	1
Pfister, SM	1
Boissel, JP; Gent, M; Harker, LA; Pilgrim, AJ	1
Ikeda, Y	1
van Kranen, RJ	1
Walvoort, HC	1
Einecke, D	1
Hohlfeld, T	1
Jarvis, B; Simpson, K	1
Montalescot, G	1
Bennett, JS	1
Bogousslavsky, J	1
Scheen, AJ	1
Zusman, RM	2
Guile, SD; Ince, F; Ingall, AH; Kindon, ND; Meghani, P; Mortimore, MP	1
Ciuffetti, G; Lombardini, R; Lupattelli, G; Mannarino, E; Pirro, M	1
Hiatt, WR	1
Cohn, PF	1

Reviews

26 review(s) available for clopidogrel and Arteriosclerosis

Article	Year
[Thienopyridines in the treatment and prevention of cardiovascular diseases. Part V. Combination of clopidogrel and acetylsalicylic acid in the treatment of stable patients with atherothrombotic cardiovascular diseases]. Kardiologiia, 2010, Volume: 50, Issue:5 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Arteriosclerosis; Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Circulation; Death, Sudden, Cardiac; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Streptokinase; Stroke; Thrombosis; Ticlopidine; Time Factors	2010
Platelets: is aspirin sufficient or must we know how to pronounce abciximab? Seminars in vascular surgery, 2002, Volume: 15, Issue:4 Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Blood Platelets; Clopidogrel; Endarterectomy, Carotid; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Ticlopidine; Tirofiban; Tyrosine	2002
[Platelet inhibitors: old and new]. La Tunisie medicale, 2002, Volume: 80, Issue:8 Suppl Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Thromboxanes; Ticlopidine	2002
[Clopidogrel: background information and use in clinical practice]. Ugeskrift for laeger, 2003, Apr-28, Volume: 165, Issue:18 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Stroke; Thrombosis; Ticlopidine	2003
Antiplatelet agents in atherothrombotic diseases. Hospital medicine (London, England : 1998), 2004, Volume: 65, Issue:2 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Humans; Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine	2004
Clopidogrel's role in the management of atherosclerotic disease: a focus on acute coronary syndromes. Expert review of cardiovascular therapy, 2003, Volume: 1, Issue:4 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Stents; Ticlopidine; Treatment Outcome; Vascular Diseases	2003
Clopidogrel in the management of cerebrovascular events. International journal of clinical practice, 2004, Volume: 58, Issue:4 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Drug Costs; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Ticlopidine	2004
Platelet ADP receptor antagonists: ticlopidine and clopidogrel. Best practice & research. Clinical haematology, 2004, Volume: 17, Issue:1 Topics: Arteriosclerosis; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Ticlopidine; Treatment Outcome	2004
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA, 2004, Oct-20, Volume: 292, Issue:15 Topics: Administration, Oral; Angina Pectoris; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopidogrel; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Ticlopidine	2004
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:2 Topics: Adenosine Diphosphate; Animals; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Cohort Studies; Double-Blind Method; Drug Resistance; Fibrinolytic Agents; Forecasting; Humans; Membrane Proteins; Meta-Analysis as Topic; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Randomized Controlled Trials as Topic; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombophilia; Thrombosis; Ticlopidine	2005
[Mechanism and drug treatment of atherothrombosis]. Orvosi hetilap, 2005, May-15, Volume: 146, Issue:20 Suppl 2 Topics: Anticoagulants; Arteriosclerosis; Aspirin; C-Reactive Protein; CD40 Antigens; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Thrombosis; Ticlopidine	2005
Antiplatelet therapy in populations at high risk of atherothrombosis. Journal of the National Medical Association, 2006, Volume: 98, Issue:5 Topics: Arteriosclerosis; Aspirin; Chemoprevention; Clopidogrel; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine	2006
Atherosclerosis: a unifying disorder with diverse manifestations. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Oct-01, Volume: 55, Issue:19 Suppl 1 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopidine; United States	1998
Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel. Vascular medicine (London, England), 1998, Volume: 3, Issue:3 Topics: Adenosine Diphosphate; Animals; Arteriosclerosis; Aspirin; Clopidogrel; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Signal Transduction; Thrombosis; Ticlopidine	1998
Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events. Vascular medicine (London, England), 1998, Volume: 3, Issue:3 Topics: Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopidogrel; Follow-Up Studies; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Treatment Outcome	1998
[Arteriopathy of the lower limbs: toward a global medical care]. La Revue de medecine interne, 1999, Volume: 20, Issue:6 Topics: Angiography; Arterial Occlusive Diseases; Arteriosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Endothelial Growth Factors; Genetic Therapy; Humans; Iloprost; Leg; Lymphokines; Multicenter Studies as Topic; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Protein Isoforms; Randomized Controlled Trials as Topic; Tetrazoles; Ticlopidine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilator Agents	1999
Clopidogrel: a new antiplatelet agent. Connecticut medicine, 1999, Volume: 63, Issue:6 Topics: Arteriosclerosis; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopidine	1999
Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection. Clinical cardiology, 1999, Volume: 22, Issue:9 Topics: Algorithms; Arteriosclerosis; Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Critical Pathways; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Ticlopidine	1999
[Antiplatelet therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Sep-10, Volume: 88, Issue:9 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Collagen; Humans; Immunoglobulin Fab Fragments; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboembolism; Thrombophilia; Ticlopidine	1999
Clopidogrel: a review of its use in the prevention of atherothrombosis. Drugs, 2000, Volume: 60, Issue:2 Topics: Arteriosclerosis; Clinical Trials as Topic; Clopidogrel; Drug Interactions; Humans; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Stents; Thrombosis; Ticlopidine	2000
Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease. Clinical cardiology, 2000, Volume: 23 Suppl 6 Topics: Arteriosclerosis; Clopidogrel; Eptifibatide; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Tirofiban; Tyrosine	2000
Novel platelet inhibitors. Annual review of medicine, 2001, Volume: 52 Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Humans; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Treatment Outcome	2001
Benefit of ADP receptor antagonists in atherothrombotic patients: new evidence. Cerebrovascular diseases (Basel, Switzerland), 2001, Volume: 11 Suppl 2 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Thrombosis; Ticlopidine	2001
The medicinal chemistry of the P2 receptor family. Progress in medicinal chemistry, 2001, Volume: 38 Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Arteriosclerosis; Cloning, Molecular; Clopidogrel; Cystic Fibrosis; Humans; Ophthalmic Solutions; Polyphosphates; Receptors, Purinergic P2; Structure-Activity Relationship; Ticlopidine; Tissue Distribution; Uracil Nucleotides	2001
Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy. Journal of internal medicine, 2002, Volume: 251, Issue:3 Topics: Algorithms; Arteriosclerosis; Aspirin; Clopidogrel; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine	2002
Role of antiplatelet agents in cardioprotection. The American journal of managed care, 2002, Volume: 8, Issue:9 Suppl Topics: Arteriosclerosis; Aspirin; Cardiotonic Agents; Cardiovascular Diseases; Clopidogrel; Female; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine; United States	2002

Trials

15 trial(s) available for clopidogrel and Arteriosclerosis

Article	Year
Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial. Journal of atherosclerosis and thrombosis, 2021, Feb-01, Volume: 28, Issue:2 Topics: Arteries; Arteriosclerosis; Atherosclerosis; Clopidogrel; Drug Monitoring; Female; Hemorrhage; Humans; Ischemic Stroke; Male; Middle Aged; Organ Size; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Treatment Outcome	2021
[Effect of therapy with clopidogrel on walking tolerance and parameters of hemostasis in patients with atherosclerosis of lower extremities and intermittent claudication]. Kardiologiia, 2002, Volume: 42, Issue:3 Topics: Aged; Arteriosclerosis; Clopidogrel; Female; Hemostasis; Humans; Lower Extremity; Male; Middle Aged; Movement Disorders; Physical Endurance; Platelet Aggregation Inhibitors; Ticlopidine; Walking	2002
Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel. Journal of thrombosis and thrombolysis, 2002, Volume: 14, Issue:2 Topics: Aged; Arteriosclerosis; Aspirin; Blood Platelets; Brain Ischemia; C-Reactive Protein; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2002
Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data. Cerebrovascular diseases (Basel, Switzerland), 2004, Volume: 17, Issue:2-3 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thrombosis; Ticlopidine	2004
The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Platelets, 2004, Volume: 15, Issue:2 Topics: Adenosine Diphosphate; Aged; Arteriosclerosis; Aspirin; Blood Platelets; Cell Shape; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; P-Selectin; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; Serotonin; Ticlopidine	2004
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. American heart journal, 2004, Volume: 148, Issue:2 Topics: Arteriosclerosis; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Humans; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Thrombosis; Ticlopidine	2004
Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke. Platelets, 2006, Volume: 17, Issue:2 Topics: Adult; Arteriosclerosis; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; C-Reactive Protein; Clopidogrel; Cross-Sectional Studies; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Count; Platelet-Derived Growth Factor; Solubility; Stroke; Ticlopidine; Treatment Outcome; von Willebrand Factor	2006
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (London, England), 1996, Nov-16, Volume: 348, Issue:9038 Topics: Adult; Arteriosclerosis; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Myocardial Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	1996
Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thrombosis and haemostasis, 1996, Volume: 76, Issue:6 Topics: Adult; Aged; Arteriosclerosis; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine	1996
[Recent antithrombotic gold standard?]. Fortschritte der Medizin, 1997, Feb-28, Volume: 115, Issue:6 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Treatment Outcome	1997
Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events. Vascular medicine (London, England), 1998, Volume: 3, Issue:3 Topics: Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopidogrel; Follow-Up Studies; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Treatment Outcome	1998
Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis. Seminars in thrombosis and hemostasis, 1999, Volume: 25 Suppl 2 Topics: Adolescent; Adult; Age Factors; Aged; Arteriosclerosis; Bleeding Time; Clopidogrel; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine	1999
Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events. Drug safety, 1999, Volume: 21, Issue:4 Topics: Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopidogrel; Double-Blind Method; Gastrointestinal Diseases; Hemorrhage; Humans; Myocardial Infarction; Neutropenia; Platelet Aggregation Inhibitors; Stroke; Thrombocytopenia; Ticlopidine; Time Factors; Treatment Outcome	1999
[ASS or clopidogrel? In high vascular risk it is best to give both]. MMW Fortschritte der Medizin, 2000, Mar-30, Volume: 142, Issue:13 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine	2000
Clopidogrel: hemorheological effects in subjects with subclinical atherosclerosis. Clinical hemorheology and microcirculation, 2001, Volume: 25, Issue:1 Topics: Adult; Arteriosclerosis; Blood Cell Count; Blood Viscosity; Clopidogrel; Double-Blind Method; Erythrocyte Indices; Female; Fibrinogen; Hemorheology; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine	2001

Other Studies

33 other study(ies) available for clopidogrel and Arteriosclerosis

Article	Year
Reversible cerebral vasoconstriction complicating cerebral atherosclerotic vascular disease in Schimke immuno-osseous dysplasia. Neuroradiology, 2018, Volume: 60, Issue:9 Topics: Anticoagulants; Arteriosclerosis; Aspirin; Carvedilol; Child; Clopidogrel; Diagnosis, Differential; Female; Humans; Immunologic Deficiency Syndromes; Intracranial Arteriosclerosis; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Nephrotic Syndrome; Osteochondrodysplasias; Primary Immunodeficiency Diseases; Pulmonary Embolism; Vasoconstriction; Vasodilator Agents	2018
Delayed therapy with clopidogrel and everolimus prevents progression of transplant arteriosclerosis and impairs humoral alloimmunity in murine aortic allografts. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2015, Volume: 47, Issue:1 Topics: Allografts; Animals; Aorta; Arteriosclerosis; Clopidogrel; Disease Progression; Everolimus; Immunity, Humoral; Isoantibodies; Mice; Mice, Inbred C57BL; Sirolimus; Ticlopidine	2015
[Thrombocyte aggregation inhibitor after surgery for an abdominal aortic aneurysm]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:43 Topics: Aortic Aneurysm, Abdominal; Arteriosclerosis; Aspirin; Blood Vessel Prosthesis Implantation; Cardiovascular Diseases; Clopidogrel; Female; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Care; Risk Factors; Thrombosis; Ticlopidine	2008
Attenuation of transplant arteriosclerosis with clopidogrel is associated with a reduction of infiltrating dendritic cells and macrophages in murine aortic allografts. Transplantation, 2009, Jan-27, Volume: 87, Issue:2 Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Aorta, Abdominal; Arteriosclerosis; CD40 Ligand; Cell Adhesion Molecules; Chemotaxis; Clopidogrel; Dendritic Cells; Dose-Response Relationship, Drug; Down-Regulation; Histocompatibility Testing; Intercellular Adhesion Molecule-1; Interleukin-6; Lectins, C-Type; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Minor Histocompatibility Antigens; P-Selectin; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Platelet-Derived Growth Factor; Receptors, Cell Surface; RNA, Messenger; Ticlopidine; Transplantation, Homologous	2009
Combination of clopidogrel and everolimus dramatically reduced the development of transplant arteriosclerosis in murine aortic allografts. Transplant international : official journal of the European Society for Organ Transplantation, 2010, Volume: 23, Issue:9 Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Clopidogrel; Disease Models, Animal; Drug Therapy, Combination; Everolimus; Graft Rejection; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Platelet Aggregation; Platelet Aggregation Inhibitors; Sirolimus; Ticlopidine; Transplantation, Homologous; Treatment Outcome	2010
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke, 2004, Volume: 35, Issue:2 Topics: Aged; Arteriosclerosis; Aspirin; Brain Ischemia; Clopidogrel; Databases, Factual; Female; Hospitalization; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Secondary Prevention; Stroke; Survival Rate; Ticlopidine; Treatment Outcome	2004
There is no evidence that the benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke, 2004, Volume: 35, Issue:10 Topics: Arteriosclerosis; Aspirin; Brain Ischemia; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Prognosis; Risk; Ticlopidine	2004
[Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone]. MMW Fortschritte der Medizin, 2004, Volume: 146 Suppl 1 Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Male; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine	2004
[Secondary prevention after ischemic stroke. High risk patients need special protection]. MMW Fortschritte der Medizin, 2004, Volume: 146 Suppl 1 Topics: Arteriosclerosis; Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Humans; Intracranial Arteriosclerosis; Long-Term Care; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine; Treatment Outcome	2004
Clinical and angiographic outcome after interventional treatment of the iliac arteries with a new carbofilm coated stent: preliminary results. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2004, Volume: 176, Issue:11 Topics: Administration, Oral; Aged; Aged, 80 and over; Angiography; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Carbon; Clopidogrel; Constriction, Pathologic; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Iliac Artery; Injections, Intravenous; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency	2004
Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease. Current medical research and opinion, 2004, Volume: 20, Issue:11 Topics: Aged; Aged, 80 and over; Arteriosclerosis; Clopidogrel; Female; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine	2004
Long-term combination therapy with aspirin and clopidogrel. Journal of cardiovascular pharmacology and therapeutics, 2004, Volume: 9, Issue:4 Topics: Angina, Unstable; Arteriosclerosis; Aspirin; Clopidogrel; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Thrombosis; Ticlopidine; Treatment Outcome	2004
Emerging therapies: clopidogrel and aspirin. Stroke, 2005, Volume: 36, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Prevalence; Research Design; Thrombosis; Ticlopidine; Treatment Outcome	2005
[More modest use in secondary prevention, risky in primary prevention]. MMW Fortschritte der Medizin, 2006, Apr-06, Volume: 148, Issue:14 Topics: Arteriosclerosis; Aspirin; Cause of Death; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Intracranial Embolism; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Survival Rate; Ticlopidine	2006
Clopidogrel reduces the development of transplant arteriosclerosis. The Journal of thoracic and cardiovascular surgery, 2006, Volume: 131, Issue:5 Topics: Animals; Aorta; Arteriosclerosis; Clopidogrel; Disease Models, Animal; Graft Rejection; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Platelet Aggregation Inhibitors; Ticlopidine; Transplantation, Homologous	2006
[Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study]. Kardiologia polska, 2006, Volume: 64, Issue:5 Topics: Aged; Arteriosclerosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Severity of Illness Index; Thrombosis; Ticlopidine; Treatment Outcome	2006
Update on the use of antiplatelet agents in secondary stroke prevention. Journal of the National Medical Association, 2007, Volume: 99, Issue:3 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine	2007
[Spinal cord ischaemia and preoperative clopidogrel withdrawal in an arteriosclerotic patient]. Annales francaises d'anesthesie et de reanimation, 2008, Volume: 27, Issue:4 Topics: Arteriosclerosis; Clopidogrel; Female; Humans; Middle Aged; Platelet Aggregation Inhibitors; Spinal Cord Ischemia; Substance Withdrawal Syndrome; Ticlopidine	2008
Clopidogrel: a new safe and effective antiplatelet agent. But unanswered questions remain. The Medical journal of Australia, 1997, Aug-04, Volume: 167, Issue:3 Topics: Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thrombosis; Ticlopidine	1997
Anticlotting drug approved. The Nurse practitioner, 1998, Volume: 23, Issue:1 Topics: Administration, Oral; Arteriosclerosis; Clopidogrel; Contraindications; Humans; Platelet Aggregation Inhibitors; Ticlopidine; United States; United States Food and Drug Administration	1998
Clopidogrel approved on basis of CAPRIE study. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Feb-01, Volume: 55, Issue:3 Topics: Arteriosclerosis; Clopidogrel; Drug Approval; Humans; Platelet Aggregation Inhibitors; Ticlopidine; United States; United States Food and Drug Administration	1998
Clinical safety and efficacy of clopidogrel--implications of the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) study for future management of atherosclerotic disease. Clinical therapeutics, 1998, Volume: 20 Suppl B Topics: Arteriosclerosis; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine; United States; Vascular Diseases	1998
Clopidogrel for reduction of atherosclerotic events. The Medical letter on drugs and therapeutics, 1998, Jun-05, Volume: 40, Issue:1028 Topics: Administration, Oral; Arteriosclerosis; Clinical Trials as Topic; Clopidogrel; Drug Interactions; Humans; Platelet Aggregation Inhibitors; Ticlopidine	1998
[Secondary cardiovascular prevention: convincing evidence concerning clopidogrel]. Der Nervenarzt, 1998, Volume: 69, Issue:7 Suppl Ub Topics: Arteriosclerosis; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine	1998
Shifting paradigms of antiplatelet therapy: assessing new drugs versus old. Introduction. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Oct-01, Volume: 55, Issue:19 Suppl 1 Topics: Arteriosclerosis; Aspirin; Chemistry, Pharmaceutical; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopidine	1998
Rationale for antiplatelet therapy in patients with atherothrombotic disease. Vascular medicine (London, England), 1998, Volume: 3, Issue:3 Topics: Arteriosclerosis; Clopidogrel; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Epoprostenol; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Thrombosis; Ticlopidine	1998
Using clopidogrel bisulfate: a new antiplatelet drug. The Nurse practitioner, 1999, Volume: 24, Issue:9 Topics: Arteriosclerosis; Clopidogrel; Drug Costs; Drug Interactions; Drug Monitoring; Humans; Patient Education as Topic; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine	1999
[Creative mathematics with clopidogrel]. Nederlands tijdschrift voor geneeskunde, 1999, Dec-11, Volume: 143, Issue:50 Topics: Advertising; Arteriosclerosis; Clopidogrel; Data Interpretation, Statistical; Drug Industry; Humans; Mathematics; Netherlands; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine	1999
[Creative mathematics with clopidogrel; exaggeration of the preventive effect by the pharmaceutical company]. Nederlands tijdschrift voor geneeskunde, 2000, Apr-08, Volume: 144, Issue:15 Topics: Advertising; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Clopidogrel; Data Interpretation, Statistical; Humans; Mathematics; Netherlands; Placebo Effect; Platelet Aggregation Inhibitors; Ticlopidine	2000
[Clopidogrel]. Deutsche medizinische Wochenschrift (1946), 2000, Aug-04, Volume: 125, Issue:31-32 Topics: Arteriosclerosis; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2000
[Pharmacy clinics. Medication of the month. Clopidogrel (Plavix)]. Revue medicale de Liege, 2001, Volume: 56, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Myocardial Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine	2001
Clinical and economic implications of atherosclerosis. Managed care (Langhorne, Pa.), 2000, Volume: 9, Issue:5 Suppl Topics: Arteriosclerosis; Blood Platelets; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; United States	2000
Clinical and economic implications of atherosclerosis. Managed care (Langhorne, Pa.), 2000, Volume: 9, Issue:10 Suppl Topics: Arteriosclerosis; Blood Platelets; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; United States	2000